Infinium Global Research has added a new report on Genome Engineering Market. The report presents analysis of global as well as regional markets of genome engineering market over the period of 2016 to 2024.
Genome engineering market was worth XX million in 2017 and is projected to reach XX million by 2024. A genome is the genetic material of an organism. Genome engineering or genome editing is a type of genetic engineering in which DNA is inserted, modified, deleted or replaced in the genome of the living organism. Several approaches to genome editing have been developed. A recent one is known as CRISPR-Cas9, which is short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. Genome editing is of huge interest in the prevention and treatment of human diseases. Currently, most research on genome engineering is done to understand diseases using cells and animal models.
Rising prevalence of infectious diseases and cancer, and availability of research grants & funding from the government are the primary factors responsible for driving the genome engineering market. Genome engineering is widely used in biotechnology and pharmaceutical companies, these companies are constantly indulged in research and development activities to prepare an antidote for the various infectious disease and cancer that helps to augment market growth. However lack of trained professionals and adverse public perception of genetic research is likely to be the restraint for the market growth.
The use of genetic engineering to treat increasingly prevalent chronic diseases and in preparing specialized or personalized medicine can create huge growth opportunities in near future for genome engineering market.
Geographically, North America is in the leading position among the other regions with a significant market share. U.S drives the North America genome engineering market, on account of factors such as development of gene therapy, increasing use of genetically modified crops and huge government funding for genome engineering research. Europe is expected to grow at the highest CAGR during the forecast period, 2018-2024.
Recent Development- (January 2018) - The National Institutes of Health launched an effort aimed at removing barriers that slow the adoption of genome editing for treating patients. This program, Somatic Cell Genome Editing, plans to award researchers approximately $190 million over six years beginning this year. The program is funded by NIH’s Common Fund. Wherein, researchers will collaborate to improve the delivery mechanisms for targeting gene editing tools in patients, develop new and improved genome editors, develop assays for testing the safety and efficacy of the genome editing tools in animal and human cells, and assemble a genome editing toolkit containing the resulting knowledge, methods, and these tools would be shared with the scientific community.
Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global genome engineering market but also make strategic decisions to capture the most lucrative markets in the near future.
The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.
Get 15% discount for early purchase of global genome engineering market report by clicking the following link, Use code IGRD15 to request the discount in the given form
https://www.infiniumglobalresearch.com/reports/request-discount/1327
The recent report identified that North America dominated the global genome engineering market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the genome engineering market worldwide.
The report segments the global genome engineering market on the basis of Technology, Application and End-User.
Global Genome Engineering Market by Technology
· Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
· Transcription Activator-like Effector Nuclease (TALEN)
· Zinc Finger Nuclease (ZFN)
· Other Technologies
Global Genome Engineering Market by Application
· Cell Line Engineering
· Animal Genetic Engineering
· Plant Genome Engineering
· Other Applications
Global Genome Engineering Market by End-User
· Biotechnology & Pharmaceutical Companies
· Academic & Government Research Institutes
· Contract Research Organizations
Companies Profiled in the Report
· Thermo Fisher Scientific
· Merck
· Horizon Discovery Group
· Genscript
· Sangamo Biosciences
· Integrated DNA Technologies
· Lonza
· New England Biolabs
· Origene Technologies
· Transposagen Biopharmaceuticals
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
